Results 171 to 180 of about 513,363 (187)

Halogen substituted 4-thio-2'-deoxyuridines as photosensitizers for the photodynamic therapy of prostate cancer. An in vitro study.

Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy
Anna Czaja, Magdalena Datta, Janusz Rak, Magdalena Zdrowowicz   +3 more
semanticscholar   +1 more source

Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis

The Prostate, 2014
G. Gandaglia, F. Abdollah, J. Schiffmann, V. Trudeau, S. Shariat, Simon P. Kim, P. Perrotte, F. Montorsi, A. Briganti, Q. Trinh, P. Karakiewicz, Maxine Sun   +11 more
semanticscholar   +1 more source

TIMP4 expression is regulated by miR‐200b‐3p in prostate cancer cells

Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2017
M. Janiak, Wiktor Paskal, B. Rak, Filip Garbicz, Robert Jarema, K. Sikora, P. Włodarski   +6 more
semanticscholar   +1 more source

Augmenting Prostate MRI Dataset with Synthetic Volumetric Images from Zone-Conditioned Diffusion Generative Model

DGM4MICCAI@MICCAI
Oleksii Bashkanov, Marko Rak, L. Engelage, Christian Hansen   +3 more
semanticscholar   +1 more source

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study

The Prostate, 2016
M. Schweizer, Hao Wang, Brandon S. Luber, R. Nadal, A. Spitz, D. Rosen, H. Cao, E. Antonarakis, M. Eisenberger, M. Carducci, C. Paller, S. Denmeade   +11 more
semanticscholar   +1 more source

Androgeni, benigna hiperplazija prostate in rak prostate: Androgens, benign prostatic hyperplasia and prostate cancer:

2008
Benign prostatic hyperplasia is the most common benign neoplasia in men over 60 years of age, while prostate cancer affects 15 to 30% of men between 50 and70 years of age. The clinical data suggest that androgens have an importantrole in the development of these diseases: patients with genetic defects in androgen biosynthesis and action never develop ...
openaire   +1 more source

Elevation of serum levels of urokinase‐type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

The Prostate, 1999
H. Miyake, I. Hara, K. Yamanaka, K. Gohji, S. Arakawa, S. Kamidono   +5 more
semanticscholar   +1 more source

Rak prostate

2002
Šamija, Mirko, Orešić, Vladimir, Solarić, Mladen i sur.   +2 more
openaire   +2 more sources

The influences of preoperative acute urinary retention to holmium laser enucleation of prostate: Multicenter analysis

European urology. Supplement, 2018
S. Bae, B. Park, H. Chung, Y. S. Lee, H. S. Kim, S. Kang, K. Song, Y. Chang, C. Han   +8 more
semanticscholar   +1 more source

The effect of ultrasound-guided compression immediately after transrectal ultrasound-guided prostate biopsy on postbiopsy bleeding: a randomized controlled pilot study

International Urology and Nephrology, 2017
B. Park, Jung Im Kim, S. Bae, Y. Lee, S. Kang, C. Han   +5 more
semanticscholar   +1 more source